Don’t Expect Another 40% Rise in 2013 for, Inc. (AMZN)

Page 1 of 2, Inc. (NASDAQ:AMZN) finished 2012 up about 40% for the year. In doing so, the stock outpaced its revenue growth rate; the most recent 10-Q showed net revenue up 27% in the third quarter of 2012 compared to the same period in the previous year, about even with sales growth in the first half of the year. In addition, with costs rising, Amazon- which has a market capitalization of over $110 billion- reported an operating loss, and that was after only about $300 million in operating income in H1. As a result Amazon lost 30 cents per share in the first nine months of 2012. While the company should deliver profits in Q4, current analyst expectations are that it will actually be unprofitable for the year.


Expectations for 2013 come to a consensus of $1.74 in earnings per share, which implies a forward P/E of 144. Even the highest forecast from the 35 analysts used in that consensus yields a forward earnings multiple close to 70. It’s clear that any justification of Amazon’s current stock price, let alone any expectations that the stock will rise in the next year, is based on the company’s losses being temporary and on earnings growing very rapidly even past 2013. The consensus earnings growth rate for the next five years is 33%. If we compound that over five years, and apply the resulting growth to the consensus forecast for 2013, we get 2018 earnings per share of $7.24. That would still represent an earnings multiple of more than 30, after five years of the stock trading at its current levels. We think that the price is far too high to recommend buying, and, Inc. actually looks like a good short candidate.

Billionaire Ken Fisher’s Fisher Asset Management owned 2.5 million shares of, Inc. at the end of September, making it one of the ten largest single stock positions in the fund’s 13F portfolio (find more of Fisher’s favorite stocks). A pair of Tiger Cubs each had more than $200 million of their fund’s money invested in the stock as well: John Griffin’s Blue Ridge Capital reported owning 1.5 million shares while Philippe Laffont’s Coatue Management had about 790,000 shares in its own portfolio. See more stock picks from John Griffin and from Philippe Laffont. Other interest in the company made Amazon one of the ten most popular services stocks among hedge funds.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!